Skip to content
Summit Lounge

Zimbabwe Turns Down ‘Unbalanced’ US Health Aid Deal Because of Information Apprehensions

Health funding image
The offered American funding was aimed at programmes for treating and preventing HIV/Aids, tuberculosis, and malarial diseases.

Zimbabwe has declined a major US healthcare agreement worth 367 million US dollars (272 million pounds) spanning five years over the United States' request for sensitive data.

The decision became public after a internal memorandum dated December was disclosed, indicating that Head of State Emmerson Mnangagwa believed the arrangement was "lopsided".

An official representative later stated that the United States was seeking biological samples for scientific study and commercial purposes but refused to guarantee the resulting advantages from any future vaccines.

"We are forced to start the challenging and unfortunate process of scaling back our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.

The US Embassy indicated the US had provided over $1.9bn as health assistance to Zimbabwe during the past twenty years.

A physicians' group in Zimbabwe has appealed for further negotiations to reach a agreement acceptable to all parties so the country's vital HIV programme can continue.

Wider Implications

This development follows a similar situation in neighbouring Kenya, where a court suspended a related health funding agreement after legal challenges were filed about the safety of citizens' health data.

Since resuming office last year, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.

USAID had overseen assistance for the American government, but Trump claimed its expenditure was "wasteful" and his administration was pursuing government-to-government deals to enhance openness and responsibility.

Based on reports, Sixteen nations in Africa have to date agreed to similar agreements, constituting over $18.3bn of fresh investment.

Specifics of the Rejected Deal

The money for Zimbabwe was intended to funded "tackling HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.

"It is our view this partnership could have provided extraordinary benefits for Zimbabwean communities, particularly the 1.2 million men, women and children presently on HIV treatment through American-funded initiatives," Tremont added.

However, official spokesman Nick Mangwana said the proposed deal was "unequal".

"The proposal required Zimbabwe to share its biological resources and data over an extended period, with no equivalent assurance of benefiting from any scientific breakthroughs – like new medicines or tests – that could result from that provided information," his statement read.

"In essence, our country would provide the basic resources for medical research without any certainty that the final treatments would be available to our citizens should a new pandemic arise."

Sovereignty and International Frameworks

Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral health agreements were undermining structures previously set up via the international health agency.

The spokesperson gave as an example its Pandemic Benefit-Sharing framework created to manage future pandemics.

"This framework is designed to guarantee that when a country contributes its information, the benefits – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the capability to develop them."

These objections regarding the US deal "should not be misconstrued as opposition to America," Mangwana stressed.

"We welcome ongoing discussions with our US partners on how future collaboration might be structured in a way that respects the independence and dignity of each country."

Health Experts Response

A leading public health body stated it acknowledged the official position, but recommended that negotiations should continue since much of the nation's HIV programmes were funded by foreign aid.

"In cases where technical issues exist, including those relating to information security or agreement terms, these can frequently be addressed through detailed discussion and mutually agreed protections," it said.

This impasse highlights the continuing tensions between accepting crucial international aid and safeguarding a country's data in an increasingly data-driven world.

By

Kathleen Avila

A seasoned mountaineer and outdoor writer with over 15 years of experience exploring the Alps and Himalayas.

Summit Lounge

Type to search articles.